Victorville Community Resource Center Named California HUD EnVision Center
News provided by
Share this article
HACSB shares exciting news about IEHP s Victorville Community Resource Center.
RANCHO CUCAMONGA, Calif., Jan. 14, 2021 /PRNewswire/ In partnership with the Housing Authority of San Bernardino County (HACSB), Inland Empire Health Plan s (IEHP) Victorville Community Resource Center (CRC) has been designated as the first EnVision Center in San Bernardino County, the first center in HUD Region IX (AZ, CA, HI, NV) to partner with a health plan, and seventh in the state of California.
This designation, declared by the United States Department of Housing and Urban Development (HUD), highlights the center s ability and commitment to empower households with resources and support needed to become self-sufficient. Resources pertain to economic empowerment, educational advancement, health and wellness, and character leadership. Enhancing this commitment, HACSB will now be acces
Harbor Healthcare Advises Syndicate Of Specialty & Compounding Pharmacies On Its Sale
News provided by
Share this article
Share this article
LOS ANGELES, Jan. 14, 2021 /PRNewswire/ Harbor Healthcare is pleased to announce the successful sale of a multi-location syndicate of specialty & compounding pharmacies to a financial sponsored strategic acquirer. The transaction included six pharmacy locations serving patients in and around the greater Los Angeles area. The pharmacies served both compounding and specialty retail customers across a wide array of therapies. In today s rapidly changing specialty marketplace, finding an ideal buyer that both understands the business and can adequately serve the patient needs is often challenging. Working closely with the owners and understanding their short and long-term goals for both their organizations, employees, and legacy, we are extremely pleased with the outcome. We are confident the buyer will continue to drive growth for the bus
Share this article
Share this article
CARLSBAD, Calif., Jan. 14, 2021 /PRNewswire/ As scientists continue to identify new strains of the SARS-CoV-2 virus, including the B.1.1.7 UK variant that studies suggest is more transmissible, genetic sequencing is being used to track these strains and new ones that are emerging, as well as to trace transmission patterns within communities. Today, Thermo Fisher Scientific announced an extension of its SARS-CoV-2 GlobalAccess Sequencing Program to provide additional units of the Ion Torrent Genexus System and Ion GeneStudio S5 Series sequencers at a subsidized price to further support global COVID-19 research and surveillance.
Understanding the virus s genetic code and new variants is critical to assist with genetic tracing and transmission interruption efforts. Further research is also needed to determine how new strains affect people who are infected and vaccine effectiveness. Thermo Fisher s next-generation sequencing (NGS) technology
9. Kidney Disease Market Revenue and Forecasts to 2027 - Geographical Analysis
9.1 Asia Pacific: Kidney Disease Market
9.1.1 Overview
9.1.2.1 Canada: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.2.1.1 Asia Pacific: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.2.1.2 Asia Pacific: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.2.1.2.1 Asia Pacific: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.2.2 Asia Pacific: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.1.4 Japan: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
National Jewish Health and Saint Joseph Hospital Launch Robotic Bronchoscopy Program
News provided by
Share this article
Share this article
DENVER, Jan. 14, 2021 /PRNewswire/ National Jewish Health and Saint Joseph Hospital are among the first hospitals in the Rocky Mountain region to have minimally invasive robotic technology that enables physicians to obtain tissue samples from deep within the lung where 70 percent of nodules reside. It s exciting to be able to offer patients with lung nodules an alternative to surgical biopsy, said Ellen Volker, MD, MSPH, Director of Interventional Pulmonology at National Jewish Health and interventional pulmonologist at Saint Joseph Hospital. Robotic bronchoscopy allows us to reach more types of lung nodules throughout the entirety of the lung, in one minimally invasive outpatient procedure.